Guidance for Writing Comments

By AHRMM
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision making.
 

Related Resources

White Papers
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat
Webcast
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the val
Webcast
Susan Morris, CMRP, FAHRMM, health care executive, Cerner Corporation, explains the different parts of the Unique Device Identifier (UDI) and